Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

Share Price is delayed by 15 minutes
Get Live Data
174.00    0.00 (0.00%)
Bid:
166.00
Ask:
182.00
Spread: 16.00 (9.639%)
Market Cap: £104.96m
JZCP Live PriceLast checked at - London Stock Exchange

Intraday Jz Capital Share Chart

Net Asset Value(s)

23 Dec 2019 17:45

JZ Capital Partners Ltd - Net Asset Value(s)

JZ Capital Partners Ltd - Net Asset Value(s)

PR Newswire

London, December 23

JZ CAPITAL PARTNERS LIMITED (the "Company" or "JZCP")(a closed-end collective investment scheme incorporated with limited liability under the laws of Guernsey with registered number 48761)

LEI: 549300TZCK08Q16HHU44

THIS ANNOUCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014

Monthly Net Asset Value (“NAV”)

The unaudited Net Asset Value per Ordinary Share of the Company as at the close of business on November 30, 2019 was as follows:

Company Name DateNAV per Ordinary Share
JZ Capital Partners LimitedNovember 30, 2019US$ 8.54

30 November 2019

JZCP’s NAV at November 30, 2019 is $8.54 per share ($9.43 at October 31, 2019). The decrease in NAV per share of (89 cents) per share is due to investment losses of (108 cents), expenses and finance costs of (4 cents) and net FX losses of (1 cent) offset by accrued income of 1 cent, escrow receipts of 2 cents and a write-back of the Investment Adviser’s incentive fee provision of 21 cents

Investment losses of (108 cents) are comprised primarily of the write-off of the principal balance of the direct loan to Ombuds (18 cents) and a write-down of (90 cents) on the Design District assemblage in Miami, Florida (see below).

Currently, the Borrower, in which JZCP is an investor, is in negotiations with the Lender on the Design District assemblage to sign a non-binding term sheet for a Forbearance Agreement, which will relieve the Company of more than $30 million in expected carrying costs for the Design District in late 2019 and calendar year 2020. The Borrower is contemplating signing a non-binding term sheet by December 31, 2019 and a definitive Forbearance Agreement by late January 2020. As currently contemplated, the Lender will take approximately 40-60% of the equity of the Borrower upon execution of the Forbearance Agreement. Although no term sheet or definitive agreement has been executed, the Board has decided to take an approximate 50% markdown as of November 30, 2019 against JZCP’s equity value in the Design District as of August 31, 2019, in anticipation of entering into this Forbearance Agreement. A markdown of this nature was contemplated within the range included in the announcement made by the Company on October 30, 2019. Alongside the Lender, the Borrower contemplates attempting to sell the property with an ultimate anticipated sale date by the end of Q2 2020. 

Enquiries: Company website: www.jzcp.com

This announcement is issued on behalf of the Company by Sam Walden of Northern Trust International Fund Administration Services (Guernsey) Limited Email: jzcp@ntrs.com

About JZCP

JZ Capital Partners (“JZCP”) is one of the oldest closed-end investment companies listed on the London Stock Exchange. It seeks to provide shareholders with a return by investing selectively in US and European microcap companies and US real estate. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc. (“JZAI”) which is led by David Zalaznick and Jay Jordan. They have worked together for more than 35 years and are supported by teams of investment professionals in New York, Chicago, London and Madrid. JZAI’s experts work with the existing management of micro-cap companies to help build better businesses, create value and deliver strong returns for investors. For more information please visit www.jzcp.com.

Date   Source Headline
21st Jun 201112:44 pmRNSNet Asset Value(s)
21st Jun 20117:00 amRNSInterim Management Statement
26th May 20118:10 amRNSNet Asset Value(s)
24th May 20116:01 pmRNSNotice of AGM
12th May 20118:53 amRNSNet Asset Value(s)
9th May 20113:36 pmRNSDividend Declaration
9th May 20117:00 amRNSAnnual Results for Period Ending 28 February 2011
3rd May 20112:26 pmRNSNotice of Results
13th Apr 20118:33 amRNSNet Asset Value(s)
31st Mar 20113:46 pmRNSTotal Voting Rights
15th Mar 20115:07 pmRNSCapital Reorganisation
16th Feb 201110:24 amRNSNet Asset Value(s)
21st Jan 20119:02 amRNSNet Asset Value(s)
23rd Dec 201012:26 pmRNSResult of EGM
21st Dec 20104:26 pmRNSNet Asset Value(s)
21st Dec 20107:00 amRNSInterim Management Statement
14th Dec 201010:38 amRNSDisposal
9th Dec 201010:36 amRNSHolding(s) in Company
30th Nov 20107:00 amRNSEurope Fund arrangements, Fund A Documents
22nd Nov 20108:37 amRNSNet Asset Value(s)
28th Oct 20103:45 pmRNSNet Asset Value(s)
28th Oct 20107:00 amRNSHalf Yearly Report
6th Oct 20106:20 pmRNSDirector Declaration
17th Sep 20109:00 amRNSNet Asset Value(s)
19th Aug 20109:30 amRNSNet Asset Value(s)
27th Jul 20103:30 pmRNSNet Asset Value(s)
12th Jul 201011:28 amRNSDirector Declaration
22nd Jun 20102:00 pmRNSNet Asset Value(s)
22nd Jun 20107:00 amRNSInterim Management Statement
22nd Jun 20107:00 amRNSResult of AGM
28th May 20103:45 pmRNSNet Asset Value(s)
19th May 20108:45 amRNSNet Asset Value(s)
18th May 20107:00 amRNSFinal Results
13th May 201011:02 amRNSNotice of Results
30th Mar 201011:30 amRNSNet Asset Value(s)
4th Mar 20107:00 amRNSDividend Declaration
1st Mar 201010:00 amRNSNet Asset Value(s)
10th Feb 201010:00 amRNSNet Asset Value(s)
21st Dec 200911:30 amRNSNet Asset Value(s)
21st Dec 20097:00 amRNSInterim Management Statement
20th Nov 200910:30 amRNSNet Asset Value(s)
30th Oct 20092:00 pmRNSNet Asset Value(s)
30th Oct 20097:00 amRNSInterim Results
6th Oct 200910:00 amRNSNet Asset Value(s)
20th Aug 20093:58 pmRNSNet Asset Value(s)
3rd Aug 20092:03 pmRNSNet Asset Value(s)
16th Jul 20092:45 pmRNSResult of AGM
3rd Jul 200911:51 amRNSInterim Management Statement
2nd Jul 20096:12 pmRNSHolding(s) in Company
30th Jun 20094:07 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.